Study of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called FL115, given as a shot under the skin, for people with advanced solid tumors that have stopped responding to standard treatments, including checkpoint inhibitors. The goal is to see if it can help shrink or control the tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a solid tumor that is advanced or has spread, and standard treatments no longer work or you cannot tolerate them.
- You have already been treated with and progressed on checkpoint inhibitors (a type of immunotherapy).
- You have at least one tumor that can be measured on scans.
- You are able to take care of yourself (ECOG score 0-1) and have a life expectancy of at least 12 weeks.
- You have not had certain prior treatments, such as IL-2/IL-15 drugs or more than 2 checkpoint inhibitor regimens.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called FL115 combined with an immunotherapy (PD-1 antibody) for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if this combination can shrink tumors or slow their growth.
This trial tests a new medication for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This study tests a new experimental drug called BR113, given as an injection, for people with advanced solid tumor cancers that have stopped responding to standard treatments. The goal is to see if the drug is safe and effective in shrinking or controlling the cancer.
This trial tests a new drug called PTT-4256 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find the best dose and see if it helps shrink or control the cancer.
This trial tests a new drug that may help people with advanced solid tumors, including liver, stomach, and brain cancers. It is for patients whose cancer has not responded to standard treatments or who cannot have them. The study aims to find the right dose and check safety and effectiveness.
This study tests an experimental drug called SHR-4595 given as a shot (injection) to people with advanced solid tumors. The goal is to see if it is safe and how the body handles it, which might help shrink tumors or slow their growth.
Hear when a new Advanced Solid Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.